Unlock your academic potential and expand your network by joining us!

Jaime Jacqueline Jayapalan

Dr. Jaime Jacqueline Jayapalan

University of Malaya, Malaysia

Share Link

Share

Information

Dr. Jaime Jacqueline Jayapalan is a distinguished Senior Lecturer at Universiti Malaya's Department of Molecular Medicine, with a rich background in academia and research, including international experience in Sri Lanka and India. She embarked on her academic career with a First Class Honours degree in Biomedical Science from Universiti Sains Malaysia in 2005, followed by a master's in Medical Sciences from Universiti Malaya in 2009. She further enhanced her qualifications with a PhD in Biochemistry/Proteomics in 2015 and an MBA in Human Resource Management in 2021, both from Universiti Malaya. Dr. Jayapalan has demonstrated a strong capability in securing research grants, contributing significantly to advancements in her field, particularly in identifying disease biomarkers and investigating biochemical changes in diseases like prostate cancer and pancreatic ductal adenocarcinoma. Her scholarly work, which includes over 725 citations and an H-index of 16, underscores her impactful contributions to molecular medicine.

Research Keywords & Expertise

Biomarker Discovery
Cancer
Glycosylation
Proteomics
Lectin

Fingerprints

61%
Cancer
25%
Proteomics
25%
Lectin
20%
Biomarker Discovery
18%
Glycosylation

Short Biography

Dr. Jaime Jacqueline Jayapalan is a distinguished Senior Lecturer at Universiti Malaya's Department of Molecular Medicine, with a rich background in academia and research, including international experience in Sri Lanka and India. She embarked on her academic career with a First Class Honours degree in Biomedical Science from Universiti Sains Malaysia in 2005, followed by a master's in Medical Sciences from Universiti Malaya in 2009. She further enhanced her qualifications with a PhD in Biochemistry/Proteomics in 2015 and an MBA in Human Resource Management in 2021, both from Universiti Malaya. Dr. Jayapalan has demonstrated a strong capability in securing research grants, contributing significantly to advancements in her field, particularly in identifying disease biomarkers and investigating biochemical changes in diseases like prostate cancer and pancreatic ductal adenocarcinoma. Her scholarly work, which includes over 725 citations and an H-index of 16, underscores her impactful contributions to molecular medicine.